Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tetanus: pathophysiology and management

M E Ernst1, M E Klepser, M Fouts

  • 1College of Pharmacy, University of Iowa, Iowa City 52242, USA. michael-klepser@uiowa.edu

The Annals of Pharmacotherapy
|January 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compliance-Adjusted Estimates of Aspirin Effects Among Older Persons in the ASPREE Randomized Trial.

American journal of epidemiology·2023
Same author

The relationship between long-term blood pressure variability and cortical thickness in older adults.

Neurobiology of aging·2023
Same author

The Association between Metabolic Syndrome, Frailty and Disability-Free Survival in Healthy Community-dwelling Older Adults.

The journal of nutrition, health & aging·2023
Same author

Erratum: The Association Between Frailty and All-Cause Mortality in Community-Dwelling Older Individuals: An Umbrella Review.

The Journal of frailty & aging·2022
Same author

The Association between Frailty and All-Cause Mortality in Community-Dwelling Older Individuals: An Umbrella Review.

The Journal of frailty & aging·2021
Same author

Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests.

Journal of clinical microbiology·2020
Same journal

Association Between Prior PARP Inhibitor Maintenance Therapy and Myelosuppression During Subsequent Chemotherapy in Ovarian Cancer.

The Annals of pharmacotherapy·2026
Same journal

Prolonged Response to Nivolumab in Metastatic Vulvar Carcinoma: Should Immunotherapy be Continued and for How Long? A Debatable Issue!

The Annals of pharmacotherapy·2026
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
See all related articles

Tetanus remains a significant threat, with high mortality despite decreased case numbers. Early recognition and prompt management, including immunization and supportive care, are crucial for patient survival.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Immunology

Background:

  • Tetanus, caused by Clostridium tetani, presents a persistent public health challenge.
  • While incidence has declined, mortality rates for diagnosed tetanus remain alarmingly high, particularly in elderly populations.

Purpose of the Study:

  • To comprehensively review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management strategies for tetanus.
  • To highlight the critical importance of understanding tetanus for effective clinical practice.

Main Methods:

  • A thorough literature search was conducted using MEDLINE and Iowa Drug Information Services databases.
  • Additional relevant articles were identified through the bibliographies of selected sources.

Related Experiment Videos

Main Results:

  • Tetanus cases have decreased since 1947, but mortality remains high, with the elderly being especially vulnerable.
  • Effective management includes airway stabilization, preventing toxin absorption with tetanus immune globulin, eradicating bacteria with antibiotics (metronidazole), and supportive care with muscle relaxants and autonomic dysfunction management.

Conclusions:

  • Tetanus, though infrequent, carries a high mortality risk for untreated individuals.
  • Healthcare providers must possess thorough knowledge of tetanus pathophysiology, clinical signs, and management protocols to combat this potentially fatal illness.